The reported statements, read against the company's own industry.
Financials view
Market Capitalization
58.86BTRY
1.17B · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
385.25x
Updated Oct 24, 2026
Revenue (TTM)
9.73BTRY
193.69M · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
13.78%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives 17.32%.Updated Oct 24, 2026
52-Week Change
281.43%
vs all stocks
Updated Oct 24, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
58.86BTRY
1.17B · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
78.71BTRY
1.57B · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
385.25x
Updated Oct 24, 2026
PEG Ratio
-3.24x
Updated Oct 24, 2026
Price to Sales (TTM)
5.58x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 6.05×.Updated Oct 24, 2026
Price to Book (MRQ)
1.57x
Updated Oct 24, 2026
Enterprise to Revenue
7.47x
Provider-reported. Enterprise Value ÷ Revenue (TTM) on this page gives 8.09×.Updated Oct 24, 2026
Enterprise to EBITDA
6.15x
Updated Oct 24, 2026
Gross Margin
9.02%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 6.76%.Updated Oct 24, 2026
Profit Margin
13.78%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives 17.32%.Updated Oct 24, 2026
Return on Assets (TTM)
13.50%
Updated Oct 24, 2026
Return on Equity (TTM)
4.48%
Updated Oct 24, 2026
Revenue (TTM)
9.73BTRY
193.69M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
2.80TRYUpdated Oct 24, 2026
Quarterly Revenue Growth
11.40%
Updated Oct 24, 2026
Gross Profit (TTM)
658.26MTRY
13.10M · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
1.69BTRY
33.55M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
47.14%
Updated Oct 24, 2026
Operating Cash Flow (TTM)
4.66BTRY
92.67M · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
1.69BTRY
33.55M · vs all stocks (USD)
Updated Oct 24, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 24, 2026
Trailing Annual Dividend Rate
0.00TRYUpdated Oct 24, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 24, 2026
Payout Ratio
0.00%
Updated Oct 24, 2026
Minority Interest (Equity)
13.96MTRYFY2025 · Dec 31, 2025
Revenue
9.73BTRYFY2025 · Dec 31, 2025
Cost of Goods Sold
9.07BTRYFY2025 · Dec 31, 2025
Gross Profit
658.26MTRYFY2025 · Dec 31, 2025
Operating Income
201.24MTRY
4.00M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
2.80BTRYFY2025 · Dec 31, 2025
Income Tax Expense
1.11BTRYFY2025 · Dec 31, 2025
Net Income
1.69BTRYFY2025 · Dec 31, 2025
EBIT
4.96BTRYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-13.35BTRYFY2025 · Dec 31, 2025
Selling, General & Administrative
176.57MTRYFY2025 · Dec 31, 2025
Other Operating Expenses
45.55MTRYFY2025 · Dec 31, 2025
Non-operating Interest Income
426.34MTRYFY2025 · Dec 31, 2025
Non-operating Interest Expense
2.16BTRYFY2025 · Dec 31, 2025
EPS (Basic)
0.0450TRYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0450TRYFY2025 · Dec 31, 2025
Basic Shares Outstanding
3.78BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
3.78BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
1.69BTRYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-318.00KTRYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025
Operating Cash Flow
9.60BTRYFY2025 · Dec 31, 2025
Free Cash Flow
9.56BTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.20BTRYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
1.69BTRYFY2025 · Dec 31, 2025
Other Non-cash Items
8.44BTRYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-118.97MTRYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-411.58MTRYFY2025 · Dec 31, 2025
Capital Expenditures
-35.14MTRYFY2025 · Dec 31, 2025
Net Acquisitions
-141.06MTRYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-176.20MTRYFY2025 · Dec 31, 2025
Long-term Debt Issuance
185.11MTRYFY2025 · Dec 31, 2025
Long-term Debt Payments
-5.93BTRYFY2025 · Dec 31, 2025
Other Financing Charges
261.72MTRYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.83BTRYFY2025 · Dec 31, 2025
Shares Outstanding
3.82BSharesUpdated Oct 24, 2026
% Held by Insiders
89.50%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
0.19%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
12.82MTRY
255.23K · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
0.1970TRYUpdated Oct 24, 2026
Total Debt (MRQ)
20.64BTRY
410.70M · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.5485x
Updated Oct 24, 2026
Current Ratio (MRQ)
1.49x
Updated Oct 24, 2026
Book Value per Share (MRQ)
9.84TRYUpdated Oct 24, 2026
Total Assets
58.13BTRY
1.16B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
9.67BTRYFY2025 · Dec 31, 2025
Total Liabilities
26.44BTRYFY2025 · Dec 31, 2025
Total Non-current Assets
48.46BTRYFY2025 · Dec 31, 2025
Total Non-current Liabilities
19.92BTRYFY2025 · Dec 31, 2025
Total Current Liabilities
6.52BTRYFY2025 · Dec 31, 2025
Cash
6.54MTRYFY2025 · Dec 31, 2025
Cash Equivalents
1.20BTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.21BTRYFY2025 · Dec 31, 2025
Accounts Receivable
2.26BTRYFY2025 · Dec 31, 2025
Inventory
543.06MTRYFY2025 · Dec 31, 2025
Accounts Payable
2.05BTRYFY2025 · Dec 31, 2025
Short-term Debt
4.17BTRYFY2025 · Dec 31, 2025
Long-term Debt
16.89BTRYFY2025 · Dec 31, 2025
Common Stock (Book)
636.58MTRYFY2025 · Dec 31, 2025
Retained Earnings
17.08BTRYFY2025 · Dec 31, 2025
Total Shareholders' Equity
31.70BTRY
630.80M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
142.42MTRYFY2025 · Dec 31, 2025
52-Week Low
3.34TRYUpdated Oct 24, 2026
52-Week High
19.52TRYUpdated Oct 24, 2026
52-Week Change
281.43%
vs all stocks
Updated Oct 24, 2026
50-Day MA
16.51TRYUpdated Oct 24, 2026
200-Day MA
11.05TRYUpdated Oct 24, 2026
Avg 10-Day Volume
15.89MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
16.28MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
0.0400TRYUpdated Oct 24, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.